Communiqués Solana Company

Actions

HSDT

US42328V8761

Gestion des placements et exploitants de fonds

Marché Fermé - Nasdaq 22:00:00 13/08/2026			Varia. 5j.	Varia. 1 janv.
1,800 ^USD	+3,45%		+7,14%	-37,72%

23/07	Streamex détaille l'infrastructure de liquidité du GLDY	MT
23/07	Le projet qui fait déjà trembler les géants des stablecoins

Communiqués

13/07	Solana : Initial Statement of Beneficial Ownership (Form 3)	PU
05/11	Solana Company (NASDAQ: HSDT) Releases Investor Update	AQ
04/11	Solana Company Files Application to Cease to Be a Reporting Issuer in Canada	AQ
03/11	Solana Company (NASDAQ: HSDT) Releases Investor Update	AQ
29/10/25	Solana Company Announces Updated SOL Holdings and Industry Leading Staking Yield	AQ
13/10/25	Solana Company NASDAQHSDT Selects BitGo as Custodian for SOL Treasury Holdings	AQ
13/10/25	Solana Company (NASDAQ:HSDT) Selects BitGo as Custodian for SOL Treasury Holdings	AQ
10/10/25	Solana Company (NASDAQ:HSDT) Selects BitGo as Custodian for SOL Treasury Holdings	BU
10/10/25	Preeminent SOL Treasury Vehicle, Solana Company (NASDAQ:HSDT), Adds Coinbase, BitGo, and Anchorage Digital as Custodians	AQ
06/10/25	Solana Company (NASDAQ:HSDT), Formerly Helius, Continues Amassing SOL, the Native Asset of Solana Blockchain	AQ
25/09/25	Helius Announces FDA 510(k) Submission for PoNS® Device Label Expansion in Stroke	AQ
18/09/25	Helius (NASDAQ:HSDT), in Partnership with Pantera Capital and Summer Capital Closes Over $500 Million Private Placement to Launch SOL Treasury Company	PR
15/09/25	Helius (NASDAQ:HSDT), in Partnership with Pantera Capital and Summer Capital Announces Over $500 Million in Funding to Launch SOL Treasury Company	PR
13/06/25	Helius Medical Technologies, Inc. - Positive PoNSTEP Study Results Presented at Consortium of Multiple Sclerosis Centers Annual Meeting	AQ
12/06/25	Helius Medical Technologies, Inc. Announces Authorized Claim for Payment by Major Healthcare Payer for its Portable Neuromodulation Stimulator Device	AQ
11/06/25	Helius Medical Technologies, Inc. Announces Authorized Claim for Payment by Major Healthcare Payer for its Portable Neuromodulation Stimulator (PoNS®) Device	AQ
05/06/25	Helius Medical Technologies Announces Pricing of $9.1 Million Public Offering	AQ
04/06/25	Helius Medical Technologies, Inc. Compliant with Nasdaq Bid Price Rule Listing Criteria	AQ
20/05/25	Helius to Spotlight Study Confirming Improved Long-Term Outcomes from Adherence to PoNS Therapy® at CMSC Annual Meeting	AQ
12/05/25	Helius Medical Technologies, Inc. Announces Reimbursement by Major Healthcare Provider for its Portable Neuromodulation Stimulator (PoNS®) Device	AQ
13/03/25	Helius Medical Technologies, Inc. Announces the Establishment of a Wholly Owned Brain Computer Interface (“BCI”) Technology Private Subsidiary	AQ
12/03/25	Helius Medical Technologies, Inc. Announces First Reimbursement by a Major Healthcare Provider for its Portable Neuromodulation Stimulator Device	AQ
22/01/25	Helius Medical Technologies, Inc. Announces Exercise of Warrants and Issuance of New Warrants in a Private Placement for $3.7 Million Gross Proceeds Priced At-the-Market	AQ
23/12/24	Helius Medical Technologies : Announces First Portable Neuromodulation Stimulator (PoNS®) System Sale to the Veterans Affairs (VA) Healthcare System Form 8 K	PU
18/11/24	Helius Medical Technologies : Announces Exploration of Strategic Alternatives Form 8 K	PU